Systemic (serum) Soluble Interleukin-2 Receptor Levels in Corneal Transplant Recipients

Overview

Journal Doc Ophthalmol

Specialty Ophthalmology

Date 1993 Jan 1

PMID 8334924

Authors

C S Foster

H K Wu

A Merchant

Affiliations

Soon will be listed here.

Abstract

Elevated soluble interleukin-2 receptor levels (sIL-2R), a measure of T cell activation, have been used as a serum marker for early rejection in solid organ transplant patients. In this preliminary study, we measured sequential sIL-2R levels of 53 otherwise immunologically normal corneal transplant recipients. Eleven of these transplants rejected; sIL-2R was significantly elevated during the acute rejection episode, compared to pre-rejection and post-rejection levels (p = 0.01). Five patients' sIL-2R rose one to nine months prior to rejection. These data indicate that sIL-2R levels may correlate with corneal graft rejection and may be predictive of impending rejection. A larger prospective study with many immunologically normal patients and careful monitoring of sIL-2R levels prior to and during the acute rejection episode will be necessary to determine the value of sIL-2R monitoring as a predictive tool for corneal graft rejection.

References

Williams K, Coster D . The role of the limbus in corneal allograft rejection. Eye (Lond). 1989; 3 ( Pt 2):158-66. DOI: 10.1038/eye.1989.23. View

Lawrence E, Holland V, Young J, Windsor N, Brousseau K, Noon G . Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation. Am Rev Respir Dis. 1989; 140(3):789-96. DOI: 10.1164/ajrccm/140.3.789. View

Rubin L, Nelson D . The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med. 1990; 113(8):619-27. DOI: 10.7326/0003-4819-113-8-619. View

Young E, Stark W . Immunology of corneal allograft rejection. Associated human leucocyte populations. Ophthalmology. 1985; 92(2):223-7. DOI: 10.1016/s0161-6420(85)34053-8. View

Kelenhegyi C, Suveges I, ALBERTH B . Change of T-lymphocyte ratio after keratoplasty. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979; 210(4):269-74. View

Steinmuller D . Which T cells mediate allograft rejection?. Transplantation. 1985; 40(3):229-33. DOI: 10.1097/00007890-198509000-00001. View

Holland E, Chan C, Wetzig R, Palestine A, Nussenblatt R . Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea. 1991; 10(5):374-80. DOI: 10.1097/00003226-199109000-00003. View

Rubin L, Kurman C, FRITZ M, Biddison W, Boutin B, Yarchoan R . Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985; 135(5):3172-7. View

Colvin R . Cellular and molecular mechanisms of allograft rejection. Annu Rev Med. 1990; 41:361-75. DOI: 10.1146/annurev.me.41.020190.002045. View

10.

Peeler J, Callanan D, Luckenbach M, Niederkorn J . Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders. J Exp Med. 1988; 168(5):1749-66. PMC: 2189097. DOI: 10.1084/jem.168.5.1749. View

11.

Jager M, Volker-Dieben H, Vos A, Broersma L, Kok F, van der Gaag R . Cellular and humoral anticorneal immune response in corneal transplantation. Arch Ophthalmol. 1991; 109(7):972-7. DOI: 10.1001/archopht.1991.01080070084040. View

12.

Pepose J, Nestor M, Gardner K, FOOS R, Pettit T . Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch Clin Exp Ophthalmol. 1985; 222(3):128-33. DOI: 10.1007/BF02173536. View

13.

Badenoch P, Finlay-Jones J, Coster D . Enzymatic disaggregation of the infected rat cornea. Invest Ophthalmol Vis Sci. 1983; 24(2):253-7. View

14.

Coster D . Mechanisms of corneal graft failure: the erosion of corneal privilege. Eye (Lond). 1989; 3 ( Pt 3):251-62. DOI: 10.1038/eye.1989.35. View

15.

Cornaby A, Simpson M, Madras P, Dempsey R, Clowes G, Monaco A . Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection. Transplant Proc. 1989; 21(1 Pt 2):1861-2. View

16.

Niederkorn J, Peeler J, Ross J, Callanan D . The immunogenic privilege of corneal allografts. Reg Immunol. 1989; 2(2):117-24. View

17.

Adams D, Wang L, Hubscher S, Elias E, Neuberger J . Soluble interleukin-2 receptors in serum and bile of liver transplant recipients. Lancet. 1989; 1(8636):469-71. DOI: 10.1016/s0140-6736(89)91368-8. View

18.

Stark W . Transplantation immunology of penetrating keratoplasty. Trans Am Ophthalmol Soc. 1980; 78:1079-117. PMC: 1312166. View

19.

Morgan D, Ruscetti F, Gallo R . Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976; 193(4257):1007-8. DOI: 10.1126/science.181845. View

20.

Siegert W, Josimovic-Alasevic O, Schwerdtfeger R, Baurmann H, Schmidt C, Musch R . Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant. 1990; 6(2):97-101. View